At the J.P. Morgan Healthcare Conference in San Francisco three weeks ago, it was all rainbows and unicorns when it came to the biotech sector.
At that point, the sector had climbed 50% over the previous year and 140% since the recent low in...
Idenix Pharmaceuticals Inc. (IDIX)
32nd Annual JPMorgan Healthcare Conference Call
January 15, 2014 2:00 pm ET
Ronald C. Renaud, Jr. - President and Chief Executive Officer
Geoff Meacham - JPMorgan
Sweden—Medivir AB (STO:MVIR-B), announces that Idenix Pharmaceuticals,
Inc. today released interim data from the ongoing phase II HELIX-1
clinical trial evaluating an all-oral, direct-acting antiviral...
Idenix Pharmaceuticals Inc. (IDIX) was a big mover last session, as the company saw its shares jump over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend...
Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) 33.7% HIGHER; up 120 percent from a close at $7.15 last Thursday. Last Friday, the company announced successful results in a clinical trial testing the pharmacokinetic dose response of its oral insulin...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.